Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Hach Company Responds to Storm Sandy

Published: Monday, November 05, 2012
Last Updated: Monday, November 05, 2012
Bookmark and Share
A dedicated support hotline has been established to help customers.

In response to Storm Sandy, Hach Company is supporting those impacted by the recent storm through a variety of initiatives.

A dedicated support hotline for those with storm-related questions has been established to help customers whose facilities and equipment have been affected.

Call 1-800-227-4224, option 8. All calls, service requests and new orders will be given priority status to ensure that customers are able to be up and running as quickly as possible to minimize the negative impact on communities.

In addition, Hach has proactively communicated with customers in states impacted by Sandy.

Email messages were sent encouraging them to contact Hach with any questions or challenges related to their facilities.

Regular updates will also be posted on a variety of social media channels including Facebook ( and Twitter ( letting customers know how Hach is able to help them with their facilities and equipment in the storm’s aftermath.

A comprehensive Information Center has been created and can be accessed at and will be updated on an ongoing basis. Be sure to check back often for updates.

Hach is also encouraging all associates to support the American Red Cross ( as they continue their efforts to help all those who have found themselves in need as a result of the storm.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Hach Plans Multimillion-dollar Expansion
Hach to expand facilities in Loveland, Colo.
Friday, January 22, 2016
Hach Announces 2011 BIG Picture Contest Grand Prize Winners
Eight other plants expects to receive the Fan Favorite prize of $40,000 in Hach equipment.
Friday, November 11, 2011
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Gene Therapy Going Global with Portable Device
Portable 'gene therapy in a box' could make future cancer and HIV cures affordable in developing countries.
Preventing "Friendly Fire" in the Pancreas
Researchers inhibit process that leads to the body attacking its own insulin-producing cells.
3D-Printed Heart-On-A-Chip with Integrated Sensors
Researchers have created the first 3D-printed organ-on-a-chip with integrated sensors, paving the way for more complex, customizable devices.
Wrapping up the Genome
Researchers successfully package complete yeast genome using purified components, yielding new insights into genome mechanisms.
Drug Target for Triple-Negative Breast Cancer Found
A team of researchers led by UC San Francisco scientists has identified a new drug target for triple-negative breast cancer.
Precision Medicine Guiding Cancer Patients’ Chemotherapy Decision
New study finds doctors use genetic test to measure breast cancer recurrence risk, make tailored treatment recommendations.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos